Literature DB >> 28985863

Early declaration of death by neurologic criteria results in greater organ donor potential.

Shelby Resnick1, Mark J Seamon1, Daniel Holena1, Jose Pascual1, Patrick M Reilly1, Niels D Martin2.   

Abstract

BACKGROUND: Aggressive management of patients prior to and after determination of death by neurologic criteria (DNC) is necessary to optimize organ recovery, transplantation, and increase the number of organs transplanted per donor (OTPD). The effects of time management are understudied but potentially pivotal component. The objective of this study was to analyze specific time points (time to DNC, time to procurement) and the time intervals between them to better characterize the optimal timeline of organ donation.
METHODS: Using data over a 5-year time period (2011-2015) from the largest US OPO, all patients with catastrophic brain injury and donated transplantable organs were retrospectively reviewed. Active smokers were excluded. Maximum donor potential was seven organs (heart, lungs [2], kidneys [2], liver, and pancreas). Time from admission to declaration of DNC and donation was calculated. Mean time points stratified by specific organ procurement rates and overall OTPD were compared using unpaired t-test.
RESULTS: Of 1719 Declaration of Death by Neurologic Criteria organ donors, 381 were secondary to head trauma. Smokers and organs recovered but not transplanted were excluded leaving 297 patients. Males comprised 78.8%, the mean age was 36.0 (±16.8) years, and 87.6% were treated at a trauma center. Higher donor potential (>4 OTPD) was associated with shorter average times from admission to brain death; 66.6 versus 82.2 hours, P = 0.04. Lung donors were also associated with shorter average times from admission to brain death; 61.6 versus 83.6 hours, P = 0.004. The time interval from DNC to donation varied minimally among groups and did not affect donation rates.
CONCLUSIONS: A shorter time interval between admission and declaration of DNC was associated with increased OTPD, especially lungs. Further research to identify what role timing plays in the management of the potential organ donor and how that relates to donor management goals is needed.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain death declaration; Donor management guidelines; Lung transplantation; Organ donor management; Transplant donor pool

Mesh:

Year:  2017        PMID: 28985863      PMCID: PMC5803185          DOI: 10.1016/j.jss.2017.05.032

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  19 in total

1.  Impact of deceased organ donor demographics and critical care end points on liver transplantation and graft survival rates.

Authors:  Matthew B Bloom; Shariq Raza; Akash Bhakta; Tyler Ewing; Madhukar Patel; Eric J Ley; Daniel R Margulies; Ali Salim; Darren Malinoski
Journal:  J Am Coll Surg       Date:  2014-10-13       Impact factor: 6.113

2.  The effect of a protocol of aggressive donor management: Implications for the national organ donor shortage.

Authors:  Ali Salim; Matthew Martin; Carlos Brown; Peter Rhee; Demetrios Demetriades; Howard Belzberg
Journal:  J Trauma       Date:  2006-08

Review 3.  Guidelines for maintenance of adult patients with brain death and potential for multiple organ donations: the Task Force of the Brazilian Association of Intensive Medicine the Brazilian Association of Organs Transplantation, and the Transplantation Center of Santa Catarina.

Authors:  G A Westphal; M Caldeira Filho; A Fiorelli; K D Vieira; V Zaclikevis; M Bartz; R Wanzuita; C Teixeira; C Franke; F O Machado; G Friedman; J Andrade; J D Matos; D M Lamgaro; E Silva; G Costa; M E Coelho; M C Oliveira; N C M Youssef; N Akamine; P Duarte; R Lisboa; M Mazzali; B H Ferraz Neto
Journal:  Transplant Proc       Date:  2012-10       Impact factor: 1.066

4.  Impact of catastrophic brain injury guidelines on donor management goals at a level I trauma center.

Authors:  L Quinn; W McTague; J P Orlowski
Journal:  Transplant Proc       Date:  2012-09       Impact factor: 1.066

5.  Optimization of donor management goals yields increased organ use.

Authors:  Glen A Franklin; Ariel P Santos; Jason W Smith; Susan Galbraith; Brian G Harbrecht; R Neal Garrison
Journal:  Am Surg       Date:  2010-06       Impact factor: 0.688

Review 6.  Aggressive organ donor management protocol.

Authors:  Joseph DuBose; Ali Salim
Journal:  J Intensive Care Med       Date:  2008-09-24       Impact factor: 3.510

7.  The impact of meeting donor management goals on the number of organs transplanted per donor: results from the United Network for Organ Sharing Region 5 prospective donor management goals study.

Authors:  Darren J Malinoski; Madhukar S Patel; Michael C Daly; Chrystal Oley-Graybill; Ali Salim
Journal:  Crit Care Med       Date:  2012-10       Impact factor: 7.598

8.  The impact of meeting donor management goals on the number of organs transplanted per expanded criteria donor: a prospective study from the UNOS Region 5 Donor Management Goals Workgroup.

Authors:  Madhukar S Patel; John Zatarain; Salvador De La Cruz; Mitchell B Sally; Tyler Ewing; Megan Crutchfield; C Kristian Enestvedt; Darren J Malinoski
Journal:  JAMA Surg       Date:  2014-09       Impact factor: 14.766

9.  Progression of organ failure in patients approaching brain stem death.

Authors:  F T Lytle; B Afessa; M T Keegan
Journal:  Am J Transplant       Date:  2009-03-16       Impact factor: 8.086

10.  Organ procurement in patients with fatal head injuries. The fate of the potential donor.

Authors:  R C Mackersie; O L Bronsther; S R Shackford
Journal:  Ann Surg       Date:  1991-02       Impact factor: 12.969

View more
  1 in total

Review 1.  Advances in Regenerative Medicine and Tissue Engineering: Innovation and Transformation of Medicine.

Authors:  Kevin Dzobo; Nicholas Ekow Thomford; Dimakatso Alice Senthebane; Hendrina Shipanga; Arielle Rowe; Collet Dandara; Michael Pillay; Keolebogile Shirley Caroline M Motaung
Journal:  Stem Cells Int       Date:  2018-07-30       Impact factor: 5.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.